Quantum Cyber N.V. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 12, 2026, covering the fiscal quarter ended September 30, 2026.

Key Highlights

  • Share count: As of November 12, 2026, 87,241,735 ordinary shares, par value €0.01 per share, were issued and outstanding.
  • Cash position: The company reported cash of $4,860,697 as of September 30, 2026, compared to $701,602 as of December 31, 2025.
  • Accounts receivable: Accounts receivable, net, stood at $643,386 as of September 30, 2026, versus $0 at December 31, 2025.
  • Inventories: Inventories of $929,606 were reported as of September 30, 2026, with no comparable balance at December 31, 2025.
  • Company classification: The registrant identified itself as a non-accelerated filer, smaller reporting company, and emerging growth company.
  • Material weakness: The filing acknowledged "a material weakness in our internal control over financial reporting" as an ongoing risk factor.

Quantum Cyber N.V. Balance Sheet Highlights and Disclosed Risk Factors, Q3 2026

Quantum Cyber N.V. (formerly Mainz Biomed N.V.), whose ordinary shares trade on the Nasdaq Capital Market under the symbol QUCY, submitted its quarterly report on NASDAQ:QUCY for the period ended September 30, 2026. The filing shows cash of $4,860,697 as of that date, a substantial increase from the $701,602 reported at December 31, 2025. Marketable securities of $132,003 and prepaid expenses and other current assets of $1,794,448 were also listed on the condensed consolidated balance sheet, according to the filing.

The company disclosed that it operates in multiple business lines, including drone and autonomous systems manufacturing, quantum antenna technologies under license, a metal stamping business acquired from Arcade Technology LLC, and a pancreatic cancer screening program. The filing noted that the company "has not received any purchase orders for drones" and described uncertainty as to whether its drone products "will achieve market acceptance." It also cited dependence on license agreements with BP United and Project LightShift, including the delivery by Project LightShift of "a demonstrable prototype of its quantum antenna technology."

Among the risk factors disclosed, the registrant cited its ability to continue as a going concern, the need to obtain additional financing, further potential delays in completing the build-out of its Bridgeport, Connecticut facility, and the acknowledged material weakness in internal control over financial reporting. The filing also referenced at-the-market offering activity with Titan Partners Securities LLC as a financing avenue. Forward-looking statements in the report are described as the company's own and subject to its cautionary language, with no guarantee of future performance.

What Was Disclosed

Quantum Cyber N.V. disclosed its condensed consolidated balance sheet as of September 30, 2026, operational risks across its drone, quantum, metal stamping, and cancer screening segments, a material weakness in internal controls, and 87,241,735 ordinary shares outstanding as of November 12, 2026.